Impact of Helicobacter pylori Infection on the Humoral Immune Response to MUC1 Peptide in Patients with Chronic Gastric Diseases and Gastric Cancer

REFERENCES

• Bhat N., Gaensbauer J., Peek R. M., Bloch K., Tham K. T., Blaser M. J., Perez-Perez G. Local and systemic immune and inflammatory responses to. Helicobacter pylori strains. Clin. Diagn. Lab. Immunol. 2005; 12: 1393–1400
   PubMedGoogle Scholar
• Bird J. C., Bresalier R. S. Alterations in gastric mucin synthesis by Helicobacter pylori. World J. Gastroenterol. 2000; 6: 475–482
   PubMedGoogle Scholar
• Blaser M. J., Atherton J. C. Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 2004; 113(3)321–333
   PubMed Web of Science ®Google Scholar
• Blomberg J., Nilsson I., Anderson M. Viral antibody screening system that uses a standardized single dilution immunoglobulin G enzyme immunoassay with multiple antigens. J. Clin. Microbiol. 1983; 17: 1081–1091
   PubMed Web of Science ®Google Scholar
• Bon G. G., Von Mensdorff-Pouilly S., Kenemans P., Van Kamp G. J., Verstraeten R. A., Hilgers J., Meijer S., Vermorken J. B. Clinical and technical evaluation of ACSTMBR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15–3 assays. Clin. Chem. 1997; 43: 585–593
   PubMedGoogle Scholar
• Chow W. H., Blaser M. J., Blot W. J., Gammon M. D., Vaughan T. L., Risch H. A., Perez-Perez G. I., Schoenberg J. B., Stanford J. L., Rotterdam H., West A. B., Fraumeni J. F. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinioma. Cancer Res. 1998; 58: 588–590
   PubMed Web of Science ®Google Scholar
• Crowe S. E. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr. Opin. Gastroenterol. 2005; 21: 32–38
   PubMed Web of Science ®Google Scholar
• Hamanaka Y., Suehiro Y., Fukui M., Shikichi K., Imai K., Hinoda Y. Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer. Int. J. Cancer 2003; 103(1)97–100
   PubMed Web of Science ®Google Scholar
• Henrik Siman J., Forsgren A., Berglund G., Floren C. H. Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter 2001; 6: 310–316
   PubMed Web of Science ®Google Scholar
• Hinoda Y., Nakagawa N., Nakamura H., Makiguchi Y., Itoh F., Adachi M., Yabana T., Imai K., Yachi A. Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis. Immunol. Lett. 1993; 35: 163–168
   PubMedGoogle Scholar
• Hirasawa Y., Kohno N., Yokoyama A., Kondo K., Hiwada K., Miyake M. Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer. Am. J. Resp. Crit. Care Med. 2000; 161: 589–594
   PubMed Web of Science ®Google Scholar
• Karsten U., Serttas N., Paulsen H., Danielczyk A., Goletz S. Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1). Glycobiology 2004; 14: 681–692
   PubMed Web of Science ®Google Scholar
• Karsten U., von Mensdorf-Pouilly S., Goletz S. What makes MUC1 a tumor antigen?. Tumor Biol. 2005; 26: 217–220
   PubMed Web of Science ®Google Scholar
• Klaamas K., Held M., Wadström T., Lipping A., Kurtenkov O. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int. J. Cancer 1996; 66: 1–5
   PubMedGoogle Scholar
• Klaamas K., Kurtenkov O., Brjalin V., Miljukhina L., Shljapnikova L., Engstrand L. Enhanced humoral immune response to tumor-associated T glycotope (Galβ1,3GalNAc) in Helicobacter pylori-infected patients with gastric cancer and non-tumor gastric diseases. Exp. Oncol. 2002b; 24: 38–44
   Google Scholar
• Klaamas K., Kurtenkov O., Rittenhouse-Olson K., Brjalin V., Miljukhina L., Shljapnikova L., Engstrand L. Expression of tumor-associated Thomsen-Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals. Immunol. Invest. 2002a; 31: 191–204
   PubMed Web of Science ®Google Scholar
• Kocer B., Soran A., Kiyak G., Erdogan S., Eroglu A., Bozkurt B., Solak C., Cengiz O. Prognostic significance of mucin expression in gastric carcinoma. Dig. Dis. Sci. 2004; 49: 954–964
   PubMedGoogle Scholar
• Kurtenkov O., Klaamas K., Mensdorff-Pouilly S., Miljukhina L., Shljapnikova L., Chuzmarov V. Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival. Acta Oncologica. 2007; 46: 316–323
   PubMed Web of Science ®Google Scholar
• Lauren P. The two histological main types of gastric carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 1965; 64: 31–49
   PubMedGoogle Scholar
• Lee H. S., Lee H. K., Kim H. S., Yang H. K., Kim Y. I., Kim W. H. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinoma: their roles as prognostic indicators. Cancer 2001; 92: 1427–1434
   PubMedGoogle Scholar
• Lelwala-Guruge J., Schalen C., Nilsson I., Ljungh A., Tyszkiewicz T., Wikander M., Madström T. Detection of antibodies to Helicobacter pylori cell surface antigens. Scand. J. Infect. Dis. 1990; 22: 457–465
   PubMedGoogle Scholar
• Macarthur M., Hold G. L., El-Omar E. M. Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol. Gastrointest. Liver Physiol. 2004; 286: G515–G520
   PubMed Web of Science ®Google Scholar
• Peek R. M., Blaser M. J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2002; 2: 28–37
   PubMed Web of Science ®Google Scholar
• Rad R., Prinz C., Neu B., Neuhofer M., Zeitner M., Voland P., Becker I., Schepp W., Gerard M. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J. Infect. Dis. 2003; 188: 272–281
   PubMed Web of Science ®Google Scholar
• Sheu B. S., Shiesh S. C., Yang H. B., Chen C. Y., Lin X. Z. Implications of Helicobacter pylori serological titer for the histological severity of antral gastritis. Endoscopy 1997; 29: 27–30
   PubMed Web of Science ®Google Scholar
• Slomiany B. L., Slomiany A. Up-regulation in endothelin-1 by Helicobacter pylori lipopolysaccharide interferes with gastric mucin synthesis via epidermal growth factor receptor transactivation. Scand. J. Gastroenterol. 2005; 40: 921–928
   PubMed Web of Science ®Google Scholar
• Snijdewint F. G. M., von Mensdorff-Pouilly S., Karuntu-Wanamarta A. H., Verstraeten A. A., Livingstone P. O., Hilgers J., Kenemans P. Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients. Int. J. Cancer 2001; 93: 97–101
   PubMed Web of Science ®Google Scholar
• Sobin L. H., Wittekind C. H. TNM Classification of Malignant Tumors. UICC. Wiley, New York 1997
   Google Scholar
• Tanaka S., Mizuno M., Maga T., Yoshinaga F., Tomoda J., Nasu J., Okada H., Yokota K., Oguma K., Shiratori Y., Tsuji T. H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase. Hepatogastroenterology 2003; 50(53)1739–1742
   PubMedGoogle Scholar
• Taylor-Papadimitriou J., Burchell J., Miles D. W., Dalziel M. MUC1 and cancer. Biochim. Biophys. Acta 1999; 1455: 301–313
   PubMed Web of Science ®Google Scholar
• Teixeira A., David L., Reis C. A., Costa J., Sobriho-Simoes M. Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach. J. Pathol. 2002; 197: 37–43
   PubMed Web of Science ®Google Scholar
• Troost E., Hold G. L., Smith M. G., Chow W. H., Rabkin C. S., McColl K. E., El-Omar E. M. The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk. Can. J. Gastroenterol. 2003; 17(Suppl B)8B–12B
   Google Scholar
• Vinall L. E., King M., Green C. A., Daniels G., Hilkens J., Sarner M. Swallow DM. Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology 2002; 123: 41–49
   PubMedGoogle Scholar
• Von Mensdorff-Pouilly S., Gourevitch M. M., Kenemans P., Verstraeten A. A., van Kamp G. J., Uffelen K., Snijdewint F. G. M., Paul M. A., Meijer S., Hilgers J. An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1). Tumor Biol. 1998; 19: 186–195
   PubMed Web of Science ®Google Scholar
• Von Mensdorff-Pouilly S., Snijdewint F. G. M., Verstraeten A. A., Verheijen R. H. M., Kenemans P. Human MUC1 mucin: a multifaceted glycoprotein. J. Biol. Markers 2000a; 15: 343–356
   PubMed Web of Science ®Google Scholar
• Von Mensdorff-Pouilly S., Verstraeten A. A., Kenemans P., Snijdewint F. G. M., Kok A., Van Kamp G. J., Paul M. A., Van Diest P. J., Meijer S., Hilgers J. Survival in early breast cancer patients is favourably influenced by a natural humoral immune response to polymorphic epitelial mucin (MUC1). J. Clin. Oncol. 2000b; 18: 574–583
   PubMed Web of Science ®Google Scholar
• Von Mensdorff-Pouilly S., Petrakou E., Kenemans P., Van Uffelen K., Verstraeten A. A., Snijdewint F. G. M., Van Kamp G. J., Schol D., Reis C. A., Price M. R., Livingston P. O., Hilgers J. Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and N-acetylgalactosamine (GalNAc) peptides. Int. J. Cancer 2000c; 86: 702–712
   PubMed Web of Science ®Google Scholar
• Von Mensdorf-Pouilly S., Kinarsky L., Engelmann K., Baldus S. E., Verheijen R. H., Hollingsworth M. A., Pisarev V., Sherman S., Hanish F. G. Sequence variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differencial B lymphocyte response. Glycobiology 2005; 15: 735–746
   PubMed Web of Science ®Google Scholar
• Ye W., Held M., Lagergren J., Engstrand L., Blot W. J., McLaughlin J. K., Nyren O. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J. Nat. Cancer Institute 2004; 96: 388–396
   PubMedGoogle Scholar